PRN: PioneerRx Selects Elsevier Gold Standard Drug Database

19/mag/2014 16:17:10 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

PioneerRx Selects Elsevier Gold Standard Drug Database


PHILADELPHIA, May 19, 2014 /PRNewswire/ --

Replacing existing drug database, Gold Standard Drug Database will provide tools to drive smarter drug decisions and superior decision support 

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced an agreement with PioneerRx Pharmacy Software, a fast-growing pharmacy systems vendor serving independent and small chain pharmacies. PioneerRx selected Elsevier's Gold Standard Drug Database to replace its existing drug database and provide current and accurate drug content to enhance its member products, including an alert system, and concise, complete patient education information.

With more than 1,500 retail pharmacy customers nationwide currently using the software in their pharmacies, PioneerRx selected Elsevier to help the organization and its customers improve patient safety and outcomes by providing information to pharmacists such as important drug interaction alerts, dosage parameters, drug pricing and image verification.

"After working with another module of Gold Standard Drug Database, we determined that our entire system could greatly benefit from having the most current drug information," said Jeff Key, Managing Director, PioneerRx. "Our goal of providing the most innovative technology to our patients will be reinforced with Elsevier's user-friendly drug information sheets, available in multiple languages and formatted to help consumers make educated decisions about their health and medications."

The Gold Standard Drug Database content is updated daily and has a peer-reviewed editorial process in place to ensure the highest accuracy of drug product information, drug pricing, clinical and patient education information. PioneerRx will benefit from the database's modern technical architecture, accurate content, built-in human logic and flexible implementation, all of which drive smarter drug decisions in pharmacies.

"PioneerRx shows how the superior technology of Gold Standard Drug Database makes a full replacement of another solution easy and worthwhile, even for technology vendor systems that integrate client data," said Trygve Anderson, R.Ph., Vice President, Pharmacy Solutions, Elsevier Clinical Solutions. "PioneerRx is expanding rapidly and we're looking forward to working closely with the organization to ensure that Gold Standard Drug Database continues to exceed their expectations and those of the pharmacies they serve."

For more information about Elsevier Gold Standard, go to:

About Elsevier 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey -  and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact
Christopher Capot
Director, Corporate Relations

Company Codes: EuronextAmsterdam:REN, NYSE:ENL, LSE:REL, NYSE:RUK
blog comments powered by Disqus è un servizio offerto da Factotum Srl